Currently, there are few effective treatments for the more than 150 chronic conditions classified as autoimmune diseases. Research undertaken and funded by the National Institutes of Health has advanced CAR T-cell therapy, precision immunology, and AI-driven diagnostics. This research is opening new frontiers in care and cures are on the line if we don’t continue to support the National Institutes of Health. Scientists working with NIH are on the brink of major breakthroughs. Immune-targeted therapies are reducing disease activity in various autoimmune diseases, and these new therapies promise hope.
However, recent cuts to NIH threaten the progress we’ve made. We need Congress to invest in science. We need Congress to invest in hope. We need Congress to invest in our future.